Canavan Disease clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
A Study of AAV9 Gene Therapy in Participants With Canavan Disease
Sorry, not currently recruiting here
The main objective of this trial is to evaluate the safety, tolerability, and pharmacodynamic activity of BBP-812, an investigational AAV9-based gene therapy, in pediatric participants with Canavan disease.
Oakland, California and other locations
Our lead scientists for Canavan Disease research studies include Alexander Fay, MD.
Last updated: